Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Health Catalyst, Inc - Common stock (NQ: HCAT )

5.420 -0.130 (-2.34%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Health Catalyst, Inc - Common stock

< Previous 1 2 3 4 Next >
Beyond The Numbers: 8 Analysts Discuss Health Catalyst Stock
Via Benzinga
Data Analytics Stocks Q3 Highlights: Domo (NASDAQ:DOMO)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the data analytics stocks, including Domo (NASDAQ:DOMO) and its peers. 
Via StockStory
A Look Back at Data Analytics Stocks’ Q3 Earnings: Palantir (NASDAQ:PLTR) Vs The Rest Of The Pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Palantir (NASDAQ:PLTR) and the... 
Via StockStory
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Breaking Down Health Catalyst: 8 Analysts Share Their Views
Via Benzinga
The Latest Analyst Ratings For Health Catalyst
Via Benzinga
What Analysts Are Saying About Health Catalyst Stock
Via Benzinga
Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts
Via Benzinga
Winners And Losers Of Q3: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers. 
Via StockStory
Q3 Data Analytics Earnings Review: First Prize Goes to Samsara (NYSE:IOT)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the data analytics industry, including Samsara (NYSE:IOT) and its peers. 
Via StockStory
Futures Slump As Yields, Dollar Soar
In premarket trading Quantum stocks tumbled after Nvidia CEO Jensen Huang said that “very useful” quantum computers are likely decades away. 
Via Talk Markets
Topics Commodities Stocks / Equities
Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Amplitude (NASDAQ:AMPL) and its peers. 
Via StockStory
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
Via Benzinga
The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts
Via Benzinga
A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
Via Benzinga
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings?
Over the past six months, Health Catalyst has been a great trade, beating the S&P 500 by 7.9%. Its stock price has climbed to $7.09, representing a healthy 17.2% increase. This was partly thanks to its... 
Via StockStory
Topics Stocks
Exposures US Equities
Earnings To Watch: Domo (DOMO) Reports Q3 Results Tomorrow
Data visualization and business intelligence company Domo (NASDAQ:DOMO) will be reporting earnings tomorrow after the bell. Here’s what you need to know. 
Via StockStory
What To Expect From Samsara’s (IOT) Q3 Earnings
Internet of Things company Samsara (NYSE:IOT) will be announcing earnings results tomorrow after market hours. Here’s what to look for. 
Via StockStory
Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Peeling Back The Layers: Exploring Health Catalyst Through Analyst Insights
Via Benzinga
What 7 Analyst Ratings Have To Say About Health Catalyst
Via Benzinga
Analyst Scoreboard: 5 Ratings For Health Catalyst
Via Benzinga
Health Catalyst (NASDAQ:HCAT) Posts Q3 Sales In Line With Estimates
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 3.5% year on year to $76.35 million. The company expects next quarter’s... 
Via StockStory
Health Catalyst (HCAT) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare software provider Health Catalyst (NASDAQ:HCAT) will be reporting earnings tomorrow afternoon. Here’s what to look for. 
Via StockStory
3 Overlooked Telehealth Stocks Poised for a Comeback
Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement. 
Via InvestorPlace
HCAT Stock Earnings: Health Catalyst Beats EPS, Misses Revenue for Q1 2024
HCAT stock results show that Health Catalyst beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
SMART Global Reports Q2 Results, Joins Health Catalyst And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining by around 0.1% on Wednesday. 
Via Benzinga
Demystifying Health Catalyst: Insights From 7 Analyst Reviews
Via Benzinga
Deep Dive Into Health Catalyst Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.